loader

World Tenders & Procurement Opportunities

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.

World Biggest Tenders Source

This tender with title Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens. has been published on Bidding Source portal dated 18 Oct 2019 for the country of Germany. It has been categorized on Pharmaceutical products. For similar tenders you can see tenders mentioned below of this page.

General Information

Abschluss nicht-exklusiver Rabattvereinbarungen nach § 130a Abs. 8 SGB V zu den in II.2.4. genannten Wirkstoffen mit Abschlussmöglichkeit im Rahmen des sogenannten Open-House-Verfahrens.
Contract notice
2019/S 201-487829
Germany
Germany-Hanover
18 Oct 2019
31 Dec 2021
English
Pharmaceutical products

For viewing full details of tenders, you should Log in to your account. If not registered yet, Please Register Now

Or Request a call back now and one of our representatives will contact you. Contact us

Similar Tenders

36907- Germany – Pharmaceutical products – Drug discount contracts pursuant to Section 130a Paragraph 8 of the German Social Code, Book V, within the framework of open-house procedures Germany 36740- Germany – Pharmaceutical products – Conclusion of non-exclusive discount agreements pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (Open-House Model) Germany 37275- Germany – Pharmaceutical products – Medicinal products containing the active ingredient combination timolol and latanoprost (ATC code: S01ED61 - except standard pack sizes N1-N3) Germany 37700- Germany – Pharmaceutical products – Open-House-Rabattverträge 2025-05 Germany 38439- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient liraglutide, ATC A10BJ02, for the period 01.03.2026 - 29.02.2028 (plus extension option of 1 x 12 months) Germany Awarded - 42466- Germany – Pharmaceutical products – Drug contracts with accession option Germany Awarded - 42238- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 of the German Social Code, Book V (SGB V) for the active ingredient teriflunomide, ATC L04AK02, for the period 01.10.2025 - 31.12.2025 (plus extension option of 1 x 12 months) Germany Awarded - 43976- Germany – Pharmaceutical products – Drug contracts with accession option Germany 39804- Germany – Pharmaceutical products – Conclusion of a non-exclusive discount agreement pursuant to Section 130a Paragraph 8 or 130c Paragraph 1 of the German Social Code, Book V (SGB V) for the period from March 1, 2026 to, as a rule, February 29, 2028 Germany Awarded - 41360- Germany – Pharmaceutical products – Drug contracts with accession option Germany
No. 12, 1 st floor, Block B2, EGS Business Park, World Trade Center, Bakirkoy - Istanbul - Turkey
info@biddingsource.com
24 X 7 online support
TOP
For viewing latest tenders published for your business in all over the World: Sign in Join free
For accessing full details of Tenders, Kindly choose the Plan that works for you: View Subscription Plans